Amylyx Pharmaceuticals IncNASDAQ:AMLX
- LAST PRICE3.1000
- TODAY'S CHANGE (%)0.2200 (7.6389%)
- Bid / Lots3.0900/ 31
- Ask / Lots3.1700/ 5
- Open / Previous Close2.9000 / 2.8800
- Day Range
- 52 Week Range
- Volume4,074,110
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMLX |
|---|---|---|
| 09:32 ET | 6755 | 2.875 |
| 09:34 ET | 7185 | 2.8797 |
| 09:36 ET | 16092 | 2.865 |
| 09:38 ET | 6868 | 2.8743 |
| 09:39 ET | 30947 | 2.92 |
| 09:41 ET | 36309 | 2.919 |
| 09:43 ET | 94570 | 2.93 |
| 09:45 ET | 34787 | 2.9352 |
| 09:48 ET | 6537 | 2.945 |
| 09:50 ET | 17489 | 2.938 |
| 09:52 ET | 14601 | 2.935 |
| 09:54 ET | 37994 | 2.966 |
| 09:56 ET | 49978 | 2.9891 |
| 09:57 ET | 21744 | 2.985 |
| 09:59 ET | 17066 | 3 |
| 10:01 ET | 35379 | 3.015 |
| 10:03 ET | 28909 | 3.0301 |
| 10:06 ET | 31063 | 3.0306 |
| 10:08 ET | 11031 | 3.035 |
| 10:10 ET | 15605 | 3.025 |
| 10:12 ET | 10816 | 3.0494 |
| 10:14 ET | 36278 | 3.045 |
| 10:15 ET | 54863 | 3.075 |
| 10:17 ET | 17387 | 3.07 |
| 10:19 ET | 92192 | 3.095 |
| 10:21 ET | 44179 | 3.105 |
| 10:24 ET | 97028 | 3.1387 |
| 10:26 ET | 12651 | 3.145 |
| 10:28 ET | 45955 | 3.105 |
| 10:30 ET | 10327 | 3.1189 |
| 10:32 ET | 12584 | 3.13 |
| 10:33 ET | 10488 | 3.15 |
| 10:35 ET | 7199 | 3.15 |
| 10:37 ET | 11947 | 3.14 |
| 10:39 ET | 12999 | 3.145 |
| 10:42 ET | 108536 | 3.1651 |
| 10:44 ET | 15035 | 3.1611 |
| 10:46 ET | 14493 | 3.17 |
| 10:48 ET | 12183 | 3.17 |
| 10:50 ET | 10196 | 3.185 |
| 10:51 ET | 18847 | 3.1844 |
| 10:53 ET | 86602 | 3.23 |
| 10:55 ET | 79646 | 3.2198 |
| 10:57 ET | 88024 | 3.2287 |
| 11:00 ET | 38142 | 3.215 |
| 11:02 ET | 18192 | 3.205 |
| 11:04 ET | 13881 | 3.185 |
| 11:06 ET | 31711 | 3.1311 |
| 11:08 ET | 14965 | 3.1277 |
| 11:09 ET | 11163 | 3.1299 |
| 11:11 ET | 4302 | 3.13 |
| 11:13 ET | 45265 | 3.13 |
| 11:15 ET | 3566 | 3.1495 |
| 11:18 ET | 9759 | 3.1593 |
| 11:20 ET | 27154 | 3.17 |
| 11:22 ET | 11823 | 3.155 |
| 11:24 ET | 5050 | 3.1599 |
| 11:26 ET | 1096 | 3.156 |
| 11:27 ET | 8088 | 3.16 |
| 11:29 ET | 18520 | 3.1997 |
| 11:31 ET | 23750 | 3.19 |
| 11:33 ET | 39076 | 3.1988 |
| 11:36 ET | 16904 | 3.205 |
| 11:38 ET | 32802 | 3.2389 |
| 11:40 ET | 28264 | 3.24 |
| 11:42 ET | 9211 | 3.2388 |
| 11:44 ET | 14471 | 3.2293 |
| 11:45 ET | 19257 | 3.2083 |
| 11:47 ET | 3242 | 3.1977 |
| 11:49 ET | 11900 | 3.205 |
| 11:51 ET | 3816 | 3.195 |
| 11:54 ET | 4048 | 3.1711 |
| 11:56 ET | 1775 | 3.178 |
| 11:58 ET | 5949 | 3.165 |
| 12:00 ET | 2318 | 3.16 |
| 12:02 ET | 3585 | 3.165 |
| 12:03 ET | 15713 | 3.155 |
| 12:05 ET | 3073 | 3.1552 |
| 12:07 ET | 7364 | 3.1689 |
| 12:09 ET | 3171 | 3.165 |
| 12:12 ET | 1517 | 3.17 |
| 12:14 ET | 4560 | 3.1791 |
| 12:16 ET | 19168 | 3.1637 |
| 12:18 ET | 473 | 3.1611 |
| 12:20 ET | 200 | 3.165 |
| 12:21 ET | 1216 | 3.163 |
| 12:23 ET | 524 | 3.165 |
| 12:25 ET | 32023 | 3.15 |
| 12:27 ET | 1841 | 3.155 |
| 12:30 ET | 1367 | 3.15 |
| 12:32 ET | 1595 | 3.155 |
| 12:34 ET | 5501 | 3.165 |
| 12:36 ET | 11370 | 3.145 |
| 12:38 ET | 832 | 3.135 |
| 12:39 ET | 1004 | 3.1364 |
| 12:41 ET | 4405 | 3.14 |
| 12:43 ET | 500 | 3.135 |
| 12:45 ET | 41488 | 3.145 |
| 12:48 ET | 5971 | 3.165 |
| 12:50 ET | 8752 | 3.165 |
| 12:52 ET | 4674 | 3.165 |
| 12:54 ET | 13931 | 3.17 |
| 12:56 ET | 6246 | 3.17 |
| 12:57 ET | 614 | 3.1663 |
| 12:59 ET | 760 | 3.165 |
| 01:01 ET | 5642 | 3.1699 |
| 01:03 ET | 4111 | 3.1699 |
| 01:06 ET | 960 | 3.165 |
| 01:08 ET | 6896 | 3.18 |
| 01:10 ET | 6154 | 3.185 |
| 01:12 ET | 2518 | 3.185 |
| 01:14 ET | 16647 | 3.204 |
| 01:15 ET | 13284 | 3.2194 |
| 01:17 ET | 31213 | 3.1511 |
| 01:19 ET | 9507 | 3.1879 |
| 01:21 ET | 4492 | 3.2 |
| 01:24 ET | 3981 | 3.1988 |
| 01:26 ET | 267 | 3.2 |
| 01:28 ET | 1423 | 3.2 |
| 01:30 ET | 2750 | 3.195 |
| 01:32 ET | 1400 | 3.198 |
| 01:33 ET | 10302 | 3.19 |
| 01:35 ET | 2927 | 3.1989 |
| 01:37 ET | 966 | 3.2 |
| 01:39 ET | 6822 | 3.205 |
| 01:42 ET | 8141 | 3.2187 |
| 01:44 ET | 4292 | 3.22 |
| 01:46 ET | 6966 | 3.215 |
| 01:48 ET | 20873 | 3.23 |
| 01:50 ET | 6732 | 3.2279 |
| 01:51 ET | 28445 | 3.24 |
| 01:53 ET | 500 | 3.2329 |
| 01:55 ET | 31492 | 3.24 |
| 01:57 ET | 3742 | 3.235 |
| 02:00 ET | 30646 | 3.23 |
| 02:02 ET | 5498 | 3.235 |
| 02:04 ET | 8334 | 3.235 |
| 02:06 ET | 2895 | 3.23 |
| 02:08 ET | 14198 | 3.2292 |
| 02:09 ET | 4378 | 3.23 |
| 02:11 ET | 3173 | 3.235 |
| 02:13 ET | 945 | 3.24 |
| 02:18 ET | 11364 | 3.245 |
| 02:20 ET | 22833 | 3.26 |
| 02:22 ET | 77457 | 3.255 |
| 02:24 ET | 5302 | 3.2581 |
| 02:26 ET | 6282 | 3.26 |
| 02:27 ET | 123605 | 3.265 |
| 02:29 ET | 21181 | 3.274 |
| 02:31 ET | 23710 | 3.265 |
| 02:33 ET | 5548 | 3.2588 |
| 02:36 ET | 6295 | 3.265 |
| 02:38 ET | 3079 | 3.265 |
| 02:40 ET | 44122 | 3.224 |
| 02:42 ET | 3255 | 3.2488 |
| 02:44 ET | 3000 | 3.25 |
| 02:45 ET | 100 | 3.245 |
| 02:47 ET | 6538 | 3.23 |
| 02:49 ET | 9305 | 3.24 |
| 02:51 ET | 1000 | 3.24 |
| 02:54 ET | 134 | 3.2412 |
| 02:56 ET | 645 | 3.25 |
| 02:58 ET | 16791 | 3.2312 |
| 03:00 ET | 3449 | 3.24 |
| 03:02 ET | 2284 | 3.23 |
| 03:03 ET | 100 | 3.235 |
| 03:05 ET | 8312 | 3.235 |
| 03:07 ET | 3185 | 3.235 |
| 03:09 ET | 4078 | 3.225 |
| 03:12 ET | 7711 | 3.229 |
| 03:14 ET | 460 | 3.226 |
| 03:16 ET | 2105 | 3.22 |
| 03:18 ET | 1941 | 3.225 |
| 03:20 ET | 1821 | 3.22 |
| 03:21 ET | 2105 | 3.2288 |
| 03:23 ET | 1069 | 3.23 |
| 03:25 ET | 4730 | 3.225 |
| 03:27 ET | 14265 | 3.2021 |
| 03:30 ET | 19681 | 3.215 |
| 03:32 ET | 2262 | 3.22 |
| 03:34 ET | 11897 | 3.2121 |
| 03:36 ET | 3228 | 3.215 |
| 03:38 ET | 4495 | 3.21 |
| 03:39 ET | 5057 | 3.215 |
| 03:41 ET | 16153 | 3.205 |
| 03:43 ET | 26671 | 3.2 |
| 03:45 ET | 7028 | 3.1884 |
| 03:48 ET | 13543 | 3.18 |
| 03:50 ET | 3327 | 3.1797 |
| 03:52 ET | 29485 | 3.13 |
| 03:54 ET | 76599 | 3.1 |
| 03:56 ET | 13618 | 3.11 |
| 03:57 ET | 13654 | 3.115 |
| 03:59 ET | 587034 | 3.1 |
Sep 16, 2024
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm, from 11:42AM ET on Monday Sep 16, 2024 by Dow Jones
11:42AM ET on Monday Sep 16, 2024 by Dow Jones
Aug 28, 2024
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences, from 8:30AM ET on Wednesday Aug 28, 2024 by Dow Jones
8:30AM ET on Wednesday Aug 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amylyx Pharmaceuticals Inc | 211.1M | -1.3x | --- |
Organogenesis Holdings Inc | 375.2M | -22.6x | --- |
Amarin Corporation PLC | 242.5M | -7.2x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Ironwood Pharmaceuticals Inc | 686.9M | 99.5x | --- |
Coherus BioSciences Inc | 117.5M | -2.5x | --- |
Company Information
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.
Contact Information
- Headquarters
- 43 THORNDIKE STREETCAMBRIDGE, MA, United States 02141
- Phone
- 617-682-0917
- Fax
- 302-636-5454
Executives
- Chair of the Board of Directors
- George Milne
- Co-Chief Executive Officer, Director
- Joshua Cohen
- Co-Chief Executive Officer, Director
- Justin Klee
- Chief Financial Officer
- James Frates
- Chief Legal Officer and General Counsel
- Gina Mazzariello
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $211.1M |
|---|---|
Revenue (TTM) | $298.8M |
Shares Outstanding | 68.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.45 |
Book Value | $6.40 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
